Home
Issues
Browse By Topic
Conference Correspondent
- ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
- ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Association for Value-Based Cancer Care
Value-Based Care in Myeloma

Dr Hope Rugo

Authored Articles

HER2-Positive Breast Cancer and CDK4/6 Inhibitors

Breast Cancer, SABCS Highlights

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor

Breast Cancer, SABCS Highlights

What Differentiates Abemaciclib, Ribociclib, and Palbociclib?

Breast Cancer, SABCS Highlights

CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer

Breast Cancer, SABCS Highlights

Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer

Breast Cancer, SABCS Highlights

Hot Topics at SABCS 2017

Breast Cancer, SABCS Highlights

Top Trending Articles

1.

ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026

Meg Barbor, MPH

2.

The Evolving Landscape of Lung Cancer Care

Meg Barbor, MPH

3.

Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer

Home
Issues
Browse By Topic
Conference Correspondent
- ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
- ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Association for Value-Based Cancer Care
Value-Based Care in Myeloma

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

About
About VBCC
Mission Statement
Advertising
Contact

Contribute
Submit a Manuscript
Editorial / Publishing Policies
Author Guidelines

Publications
Value-Based Cancer Care
Value-Based Care in Myeloma
Cholangiocarcinoma News

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.